Johnson & Johnson Launches Offer for Crucell

by | Dec 8, 2010 | Towing

As part of its efforts to expand into the biotech market, Johnson & Johnson is making a long-anticipated bid for Dutch vaccine maker Crucell — in spite of Crucell’s recent manufacturing troubles.
Continue read…

Novartis Discontinues Two Drug Development Programs

by | Oct 5, 2010 | Towing

Swiss pharmaceutical company Novartis announced Tuesday that it had discontinued the development of two drugs — the hepatitis C treatment Zalbin, and antifungal agent Mycograb. The company will take impairment charges of appro…